https://www.marketscreener.com/quote/stock/CRINETICS-PHARMACEUTICALS-44965100/news/Crinetics-Announces-Positive-Initial-Findings-from-Ongoing-Open-Label-Phase-2-Study-of-Paltusotine-f-45593436/?utm_source=telegram&utm_medium=social&utm_campaign=share